TY  - GEN
AU  - Vonderheide,Robert H
AU  - LoRusso,Patricia M
AU  - Khalil,Magi
AU  - Gartner,Elaina M
AU  - Khaira,Divis
AU  - Soulieres,Denis
AU  - Dorazio,Prudence
AU  - Trosko,Jennifer A
AU  - Rüter,Jens
AU  - Mariani,Gabriella L
AU  - Usari,Tiziana
AU  - Domchek,Susan M
TI  - Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells
SN  - 1557-3265
PY  - 2010///0901
KW  - Aged
KW  - Aged, 80 and over
KW  - Androstadienes
KW  - administration & dosage
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Antigens, CD
KW  - immunology
KW  - Antigens, Differentiation, T-Lymphocyte
KW  - metabolism
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Breast Neoplasms
KW  - drug therapy
KW  - CTLA-4 Antigen
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Inducible T-Cell Co-Stimulator Protein
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasms, Hormone-Dependent
KW  - T-Lymphocytes
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-10-0505
ER  -